Category Archives: Interstitial Lung Disease

COREIM’s “ILD and High-Risk Medication Prescribing: Gray Matters Segment”

I originally posted this on April 23, 2025. I’m going to review it again today so I am moving it to today. Today, I review, link to, and excerpt from COREIM‘s ILD and High-Risk Medication Prescribing: Gray Matters Segment. All … Continue reading

Posted in Core IM, CoreIM, Interstitial Lung Disease, Pulmonology | Comments Off on COREIM’s “ILD and High-Risk Medication Prescribing: Gray Matters Segment”